Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Risk factors of bronchiolitis

View through CrossRef
Background Bronchiolitis peak incidence is in children aged 2 -6months. History of atopy in parents, non-exclusive breastfeeding,exposure to cigarette smoke, and infants living in crowded areasmay be risk factors for bronchiolitis. Gestational of age at birth isalso influences the mortality oflower respiratory tract infection.Objective To evaluate the following conditions as possiblerisk factors for bronchiolitis: history of atopy, non-exclusivebreastfeeding, preterm infants, exposure to cigarette smoke, and2:: 6 persons residing in the home.Methods A sex-matched case-control study was conductedby collecting data from medical records at Sanglah Hospital,Denpasar. The case group subjects met the diagnostic criteriafor bronchiolitis and were aged 1-24 months. The control groupincluded patients with diagnoses unrelated to the respiratorysystem. Data was analyzed using bivariate (Mc.N emar) andmultivariate methods (logistic regression) with 95% confidenceintervals and statistical significance value of P <0 .05.Results There were 96 subjects in our study, consisted of 48subjects in the case group and 48 in the control group. Thecase and control groups were similar in baseline characteristics.The presence of history of atopy (OR 34.7; 95%CI 3 to 367,P=0.003), non-exclusive breastfeeding (OR 4.3; 95%CI 1.4 to13, P=0.010), exposure to cigarette smoke (OR 3; 95%CI 1 to9.2, P=0.047), and 2:: 6 persons living in the home (OR 7.9;95%CI 2.6 to 24, P<0.0001) were found to be significant riskfactors for bronchiolitis, while the preterm infants seem notsignificant as a risk factor of bronchiolitis (OR3; 95%CI 0.31 to78.99, P=0.625).Conclusion History of atopy, non-exclusive breastfeeding,exposure to cigarette smoke, and 2:: 6 persons living in the homeare found to be risk factors, while preterm infants seem not a riskfactor for bronchiolitis.
Paediatrica Indonesiana - Indonesian Pediatric Society
Title: Risk factors of bronchiolitis
Description:
Background Bronchiolitis peak incidence is in children aged 2 -6months.
History of atopy in parents, non-exclusive breastfeeding,exposure to cigarette smoke, and infants living in crowded areasmay be risk factors for bronchiolitis.
Gestational of age at birth isalso influences the mortality oflower respiratory tract infection.
Objective To evaluate the following conditions as possiblerisk factors for bronchiolitis: history of atopy, non-exclusivebreastfeeding, preterm infants, exposure to cigarette smoke, and2:: 6 persons residing in the home.
Methods A sex-matched case-control study was conductedby collecting data from medical records at Sanglah Hospital,Denpasar.
The case group subjects met the diagnostic criteriafor bronchiolitis and were aged 1-24 months.
The control groupincluded patients with diagnoses unrelated to the respiratorysystem.
Data was analyzed using bivariate (Mc.
N emar) andmultivariate methods (logistic regression) with 95% confidenceintervals and statistical significance value of P <0 .
05.
Results There were 96 subjects in our study, consisted of 48subjects in the case group and 48 in the control group.
Thecase and control groups were similar in baseline characteristics.
The presence of history of atopy (OR 34.
7; 95%CI 3 to 367,P=0.
003), non-exclusive breastfeeding (OR 4.
3; 95%CI 1.
4 to13, P=0.
010), exposure to cigarette smoke (OR 3; 95%CI 1 to9.
2, P=0.
047), and 2:: 6 persons living in the home (OR 7.
9;95%CI 2.
6 to 24, P<0.
0001) were found to be significant riskfactors for bronchiolitis, while the preterm infants seem notsignificant as a risk factor of bronchiolitis (OR3; 95%CI 0.
31 to78.
99, P=0.
625).
Conclusion History of atopy, non-exclusive breastfeeding,exposure to cigarette smoke, and 2:: 6 persons living in the homeare found to be risk factors, while preterm infants seem not a riskfactor for bronchiolitis.

Related Results

Serum Vitamin D Level in Children With Bronchiolitis
Serum Vitamin D Level in Children With Bronchiolitis
Abstract Acute bronchiolitis is the most common lower respiratory tract infection during the first year of life. Vitamin D is an important contributing factor to th...
Retrospective observational study of the influence of the COVID-19 outbreak on infants’ hospitalisation for acute bronchiolitis
Retrospective observational study of the influence of the COVID-19 outbreak on infants’ hospitalisation for acute bronchiolitis
ObjectivesAcute bronchiolitis is a major public health issue with high number of infants hospitalised worldwide each year. In France, hospitalisations mostly occur between October ...
Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis
Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis
Abstract Background: Cysteinyl leukotrienes (CysLTs), including LTC4, LTD4 and LTE4, are pivotal mediators in the pathophysiology of asthma. Aim: To determine whether CysLT levels ...
Exhaled breath condensate magnesium levels of infants with bronchiolitis
Exhaled breath condensate magnesium levels of infants with bronchiolitis
The aim of this study is to determine the exhaled breath condensate (EBC) magnesium levels of infants with bronchiolitis and to investigate their relationship with disease severity...
ACUTE BRONCHIOLITIS IN CHILDREN;
ACUTE BRONCHIOLITIS IN CHILDREN;
Objectives: To study the epidemiological and clinical features of acute bronchiolitis in children <2 years of age with mild tomoderate acute bronchiolitis. Study design: Descrip...
Intrapulmonary percussive ventilation for children with bronchiolitis on non-Invasive Ventilation support
Intrapulmonary percussive ventilation for children with bronchiolitis on non-Invasive Ventilation support
Objective: Pediatric Intensive Care (PICU) admission of children with bronchiolitis as well as the use of Non-Invasive Ventilation (NIV) are increasing. The current treatment for b...
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
AimsRecent conclusive evidence has suggested that, contrary to previous limited evidence, there is no benefit to the use of 3% hypertonic saline (3% HS) in the treatment of bronchi...

Back to Top